Fahrtauglichkeit bei Parkinson-Erkrankung

Die Einschätzung der Fahrtauglichkeit bei Patienten mit Parkinson-Erkrankung ist im Praxisalltag wichtig, aber schwierig und wird oft sowohl von Patienten als auch Ärzten ungern thematisiert. Dieser Beitrag zeigt, welche medizinischen Aspekte eine verminderte Fahrkompetenz entweder als fehlende generelle Fahrtauglichkeit oder als temporär eingeschränkte Fahrfähigkeit anzeigen, welche juristischen Aspekte der Arzt berücksichtigen muss und schlägt ein praxisnahes Vorgehen zur Abklärung der Fahrkompetenz vor.

Schlüsselwörter

Morbus Parkinson - Auto fahren - Führerschein - Fahrtauglichkeit - Fahrfähigkeit - Kraftfahrzeug

Publikationsverlauf

Artikel online veröffentlicht:
06. Dezember 2021

• Literatur

• 1 Meindorfner C, Korner Y, Moller JC. et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005; 20: 832-842 DOI: 10.1002/mds.20412. (PMID: 15726539)
• 2 Buhmann C, Vettorazzi E, Oehlwein C. et al. Impact of Deep Brain Stimulation on Daily Routine Driving Practice in Patients with Parkinson's Disease. Parkinsons Dis 2015; DOI: 10.1155/2015/608961.
• 3 Cordell R, Lee HC, Granger A. et al. Driving assessment in Parkinson’s disease – a novel predictor of performance?. Mov Disord 2008; 23: 1217-1222 DOI: 10.1002/mds.21762. (PMID: 18528878)
• 4 Uc EY, Rizzo M, Johnson AM. et al. Road safety in drivers with Parkinson disease. Neurology 2009; 73: 2112-2119 DOI: 10.1212/WNL.0b013e3181c67b77. (PMID: 20018639)
• 5 Wood JM, Worringham C, Kerr G. et al. Quantitative assessment of driving performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2005; 76: 176-180 DOI: 10.1136/jnnp.2004.047118. (PMID: 15654027)
• 6 Crizzle AM, Classen S, Uc EY. Parkinson disease and driving: An evidence-based review. Neurology 2012; 79: 2067-2074 DOI: 10.1212/WNL.0b013e3182749e95. (PMID: 23150533)
• 7 Gräcmann N, Albrecht M. Bundesanstalt für Straßenwesen (BASt). Begutachtungs-Leitlinien zur Kraftfahrereignung. Letzte Änderung am 2. November 2009. Carl Schünemann Verlag GmbH; 2010
• 8 Heikkila VM, Turkka J, Korpelainen J. et al. Decreased driving ability in people with Parkinson’s disease. J Neurol Neurosurg Psychiat 1998; 64: 325-330 DOI: 10.1136/jnnp.64.3.325. (PMID: 9527142)
• 9 Klimkeit EI, Bradshaw JL, Charlton J. et al. Driving ability in Parkinson’s disease: current status of research. Neurosci Biobehav Rev 2009; 33: 223-231 DOI: 10.1016/j.neubiorev.2008.08.005. (PMID: 18775450)
• 10 Buhmann C, Gerloff C. Autofahren bei Morbus Parkinson. Akt Neurol 2013; 40: 315-320
• 11 Mattern R, Körner Y, Wagenpfeil T. Fahrtüchtigkeit bei chronischen Erkrankungen – Ärzte in der Pflicht. Dtsch Med Wochenschr 2006; 131: 2200-2201
• 12 Berghaus G, Brenner-Hartmann J. Fahreignung, Fahrsicherheit und deren Begutachtung. In: Madea B, Mußhoff F, Berghaus G. Verkehrsmedizin: Fahreignung, Fahrsicherheit, Unfallrekonstruktion. Köln: Deutscher Ärzte-Verlag; 2012: 131-143
• 13 Gaidzik P. Ärztliche Beurteilung der Kraftfahreignung. In: Widder B, Gaidzik P. Begutachtungen in der Neurologie. Stuttgart: Georg Thieme Verlag; 2011: 258-259
• 14 Landesärztekammer Baden-Württemberg mit den Bezirksärztekammern. Merkblatt – Die Aufklärungspflichen des Arztes – Stand Februar 2016 (Zugriff am 31.10.2021). https://www.aerztekammer-bw.de/10aerzte/40merkblaetter/10merkblaetter/aufklaerungspflicht.pdf
• 15 Rauschelbach H-H, Jochheim K-A. Ärztliche Beurteilung der Kraftfahreignung. In: Widder B, Gaidzik PW. Begutachtung in der Neurologie. Stuttgart: Thieme; 2011: 258
• 16 Fries W, Netz J, Bötzel K. et al. Leitlinie zur Beurteilung der Fahreignung bei neurologischen Erkrankungen. Akt Neurol 2005; 32: 342-350
• 17 Singh R, Pentland B, Hunter J. et al. Parkinson’s disease and driving ability. J Neurol Neurosurg Psychiatry 2007; 78: 363-366 DOI: 10.1136/jnnp.2006.103440. (PMID: 17178820)
• 18 Dubinsky RM, Gray C, Husted D. et al. Driving in Parkinson’s disease. Neurology 1991; 41: 517-520 DOI: 10.1212/wnl.41.4.517. (PMID: 2011249)
• 19 Worringham CJ, Wood JM, Kerr GK. et al. Predictors of driving assessment outcome in Parkinson’s disease. Mov Disord 2006; 21: 230-235 DOI: 10.1002/mds.20709. (PMID: 16161149)
• 20 Uc EY, Rizzo M, Anderson SW. et al. Driving under low-contrast visibility conditions in Parkinson disease. Neurology 2009; 73: 1103-1110 DOI: 10.1212/WNL.0b013e3181bacf6e. (PMID: 19805726)
• 21 Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 2016; 15: 1257-1272 DOI: 10.1016/S1474-4422(16)30230-7. (PMID: 27751556)
• 22 Hirtz D, Thurman DJ, Gwinn-Hardy K. et al. How common are the „common“ neurologic disorders?. Neurology 2007; 68: 326-337 DOI: 10.1212/01.wnl.0000252807.38124.a3. (PMID: 17261678)
• 23 Uc EY, Rizzo M. Driving and neurodegenerative diseases. Curr Neurol Neurosci Rep 2008; 8: 377-383 DOI: 10.1007/s11910-008-0059-1. (PMID: 18713573)
• 24 Man-Son-Hing M, Marshall SC, Molnar FJ. et al. Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia. J Am Geriatr Soc 2007; 55: 878-884 DOI: 10.1111/j.1532-5415.2007.01177.x. (PMID: 17537088)
• 25 Ranchet M, Broussolle E, Paire-Ficout L. Longitudinal executive changes in drivers with parkinson’s disease: study using neuropsychological and driving simulator tasks. Eur Neurol 2016; 76: 143-150 DOI: 10.1159/000448992. (PMID: 27583361)
• 26 Devos H, Vandenberghe W, Tant M. et al. Driving and off-road impairments underlying failure on road testing in Parkinson’s disease. Mov Disord 2013; 28: 1949-1956 DOI: 10.1002/mds.25701. (PMID: 24166984)
• 27 Amick MM, Grace J, Ott BR. Visual and cognitive predictors of driving safety in Parkinson’s disease patients. Arch Clin Neuropsychol 2007; 22: 957-967 DOI: 10.1016/j.acn.2007.07.004. (PMID: 17851032)
• 28 Archibald NK, Clarke MP, Mosimann UP. et al. Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord 2011; 26: 2387-2395 DOI: 10.1002/mds.23891. (PMID: 21953737)
• 29 Uc EY, Rizzo M, Anderson SW. et al. Impaired visual search in drivers with Parkinson’s disease. Ann Neurol 2006; 60: 407-413 DOI: 10.1002/ana.20958. (PMID: 16969860)
• 30 Archibald NK, Hutton SB, Clarke MP. et al. Visual exploration in Parkinson’s disease and Parkinson’s disease dementia. Brain 2013; 136: 739-750 DOI: 10.1093/brain/awt005. (PMID: 23436502)
• 31 Chaudhuri KR, Prieto-Jurcynska C, Naidu Y. et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25: 704-709
• 32 Uitti RJ. Parkinson’s disease and issues related to driving. Parkinsonism Relat Disord 2009; 15 (Suppl. 03) 122-125 DOI: 10.1016/S1353-8020(09)70797-7. (PMID: 20082971)
• 33 Crucian GP, Armaghani S, Armaghani A. et al. Visual-spatial disembedding in Parkinson’s disease. J Clin Exp Neuropsychol 2010; 32: 190-200 DOI: 10.1080/13803390902902441. (PMID: 19484649)
• 34 Uc EY, Rizzo M, Johnson AM. et al. Real-life driving outcomes in Parkinson disease. Neurology 2011; 76: 1894-1902 DOI: 10.1212/WNL.0b013e31821d74fa. (PMID: 21624988)
• 35 Madeley P, Hulley JL, Wildgust H. et al. Parkinson’s disease and driving ability. J Neurol Neurosurg Psychiatry 1990; 53: 580-582 DOI: 10.1136/jnnp.53.7.580. (PMID: 2391522)
• 36 Lings S, Dupont E. Driving with Parkinson’s disease. A controlled laboratory investigation. Acta Neurol Scand 1992; 86: 33-39 DOI: 10.1111/j.1600-0404.1992.tb08050.x. (PMID: 1519472)
• 37 Zesiewicz TA, Cimino CR, Malek AR. et al. Driving safety in Parkinson’s disease. Neurology 2002; 59: 1787-1788 DOI: 10.1212/01.wnl.0000035636.83680.c6. (PMID: 12473772)
• 38 Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102 DOI: 10.1001/archneur.61.1.97. (PMID: 14732626)
• 39 Ondo WG, Dat VK, Khan H. et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 2001; 57: 1392-1396 DOI: 10.1212/wnl.57.8.1392. (PMID: 11673578)
• 40 Paus S, Brecht HM, Koster J. et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 2003; 18: 659-667 DOI: 10.1002/mds.10417. (PMID: 12784269)
• 41 Weintraub D, Koester J, Potenza MN. et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595 DOI: 10.1001/archneurol.2010.65. (PMID: 20457959)
• 42 Avanzi M, Baratti M, Cabrini S. et al. The thrill of reckless driving in patients with Parkinson’s disease: an additional behavioural phenomenon in dopamine dysregulation syndrome?. Parkinsonism Relat Disord 2008; 14: 257-258 DOI: 10.1016/j.parkreldis.2007.04.006. (PMID: 17561433)
• 43 Parsons TD, Rogers SA, Braaten AJ. et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588 DOI: 10.1016/S1474-4422(06)70475-6. (PMID: 16781988)
• 44 Witt K, Daniels C, Reiff J. et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614 DOI: 10.1016/S1474-4422(08)70114-5. (PMID: 18538636)
• 45 Cavanagh JF, Wiecki TV, Cohen MX. et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci 2011; 14: 1462-1467 DOI: 10.1038/nn.2925. (PMID: 21946325)
• 46 Frank MJ, Samanta J, Moustafa AA. et al. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309-1312 DOI: 10.1126/science.1146157. (PMID: 17962524)
• 47 Buhmann C, Maintz L, Hierling J. et al. Effect of subthalamic nucleus deep brain stimulation on driving in Parkinson disease. Neurology 2014; 82: 32-40 DOI: 10.1212/01.wnl.0000438223.17976.fb. (PMID: 24353336)
• 48 Buhmann C, Gerloff C. Could deep brain stimulation help with driving for patients with Parkinson’s?. Expert Rev Med Devices 2014; 11: 427-429 DOI: 10.1586/17434440.2014.929495. (PMID: 24930934)
• 49 Buhmann C, Oelsner H, Vesper J. Neurologische Leitlinie „Tiefe Hirnstimulation (THS) und Autofahren bei Morbus Parkinson“ der Arbeitsgemeinschaft Tiefe Hirnstimulation e.V. 2017
• 50 Schubert W, Schneider W, Eisenmenger W. et al. Begutachtungsleitlinien zur Kraftfahrereignung – Kommentar. 2. Aufl. Bonn: Kirschbaum; 2005
• 51 Fründt O, Fadhel M, Heesen C. et al. Do impulse control disorders impair car driving performance in patients with Parkinson’s disease? submitted.
• 52 Buhmann C, Vesper J, Oelsner H. Fahreignung bei Morbus Parkinson: Driving ability in Parkinson’s disease. Fortschr Neurol Psych 2018; 86: 43-48 DOI: 10.1055/s-0043-110051.
• 53 Classen S, Witter DP, Lanford DN. et al. Usefulness of screening tools for predicting driving performance in people with Parkinson’s disease. Am J Occup Ther 2011; 65: 579-588 DOI: 10.5014/ajot.2011.001073. (PMID: 22026326)
• 54 Lachenmayer L. Parkinson’s disease and the ability to drive. J Neurol 2000; 247 (Suppl. 04) IV/28-IV/30 DOI: 10.1007/pl00007771. (PMID: 11199814)